Unusual paraneoplastic syndromes of breast carcinoma: a combination of cerebellar degeneration and Lambert-Eaton Myasthenic Syndrome

被引:4
|
作者
Romics, L., Jr. [1 ]
McNamara, B. [2 ]
Cronin, P. A. [1 ]
O'Brien, M. E. [3 ]
Relihan, N. [1 ]
Redmond, H. P. [1 ]
机构
[1] Cork Univ Hosp, Dept Surg, Cork, Ireland
[2] Cork Univ Hosp, Dept Neurol & Neurophysiol, Cork, Ireland
[3] Univ Coll Cork, Fac Med & Hlth, Cork, Ireland
关键词
Breast neoplasms; Lambert-Eaton Myasthenic Syndrome; Paraneoplastic cerebellar degeneration; CELL LUNG-CANCER;
D O I
10.1007/s11845-008-0257-5
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Introduction Paraneoplastic neurological disorders are rare complications of breast carcinoma. Lambert-Eaton Myasthenic Syndrome (LEMS) is most commonly associated with small cell lung cancer. However, a combination of LEMS and subacute cerebellar degeneration as paraneoplastic syndromes is extremely rare, and has never been described in association with breast cancer. Case We report for the first time an unusual association of LEMS and paraneoplastic subacute cerebellar degeneration with breast carcinoma. Conclusion In patients with atypical LEMS, when there is no evidence of respiratory malignancy, breast cancer should be included in the differential diagnosis.
引用
收藏
页码:569 / 571
页数:3
相关论文
共 50 条
  • [31] The lambert-eaton myasthenic syndrome
    Antoine F. Carpentier
    Jean-Yves Delattre
    Clinical Reviews in Allergy & Immunology, 2001, 20 : 155 - 158
  • [32] Lambert-Eaton myasthenic syndrome
    Seneviratne, U
    de Silva, R
    POSTGRADUATE MEDICAL JOURNAL, 1999, 75 (887) : 516 - 520
  • [33] Lambert-eaton myasthenic syndrome
    Weimer, Maria B.
    Wong, Joaquin
    CURRENT TREATMENT OPTIONS IN NEUROLOGY, 2009, 11 (02) : 77 - 84
  • [34] Lambert-Eaton myasthenic syndrome
    Hernandez, Micaela A.
    Kohler, Alejandro A.
    Marrodan, Mariano
    Lautre, Andrea
    Brand, Patricio
    Nogues, Martin
    Barroso, Fabio
    REVISTA DE NEUROLOGIA, 2021, 73 (03) : 96 - 100
  • [35] Lambert-Eaton myasthenic syndrome
    Mareska, M
    Gutmann, L
    SEMINARS IN NEUROLOGY, 2004, 24 (02) : 149 - 153
  • [36] ANTIBODIES TO BRAIN PROTEINS IN A PATIENT WITH SUBACUTE CEREBELLAR DEGENERATION AND LAMBERT-EATON MYASTHENIC SYNDROME
    TANAKA, K
    TANAKA, M
    MIYATAKE, T
    YAMAMOTO, A
    KURAHASHI, K
    MATSUNAGA, M
    TOHOKU JOURNAL OF EXPERIMENTAL MEDICINE, 1987, 153 (02): : 161 - 167
  • [37] Paraneoplastic and non paraneoplastic Lambert-Eaton Myasthenic Syndrome: a restrospective descriptive study
    Laurenge, A.
    Maisonobe, T.
    Psimaras, D.
    Lenglet, T.
    EUROPEAN JOURNAL OF NEUROLOGY, 2020, 27 : 352 - 352
  • [38] THE INTERMITTENT MYASTHENIC SYNDROME - COMBINATION OF MYASTHENIA AND LAMBERT-EATON TYPE MYASTHENIC SYNDROME
    SANADZE, AG
    ZHURNAL NEVROPATOLOGII I PSIKHIATRII IMENI S S KORSAKOVA, 1991, 91 (09): : 93 - 97
  • [39] TRENDS IN THE ASSOCIATION OF LAMBERT-EATON MYASTHENIC SYNDROME WITH CARCINOMA
    GUTMANN, L
    PHILLIPS, LH
    GUTMANN, L
    NEUROLOGY, 1992, 42 (04) : 848 - 850
  • [40] Sox 1 antibodies are markers of paraneoplastic lambert-Eaton myasthenic syndrome
    Sabater, Lidia
    Saiz, Albert
    Titulaer, Maarten J.
    Verschuuren, Jan J.
    Francesc, Graus
    NEUROLOGY, 2007, 68 (12) : A290 - A290